Latest stories on ABBV
AbbVie (ABBV) Announces European Commission’s Approval of AQUIPTA®
Yahoo Finance67 · bullishproduct/pr
4 stocks to watch on Thursday: NFLX, PLTR, ABBV, MANU
Seeking Alpha53 · neutralgeneral
AbbVie’s ovarian cancer drug Elahere greenlighted for NHS availability
Seeking Alpha67 · bullishproduct/pr
AbbVie’s RINVOQ Safety Study In Japan: What The Latest Update Means For ABBV Investors
TipRanks53 · neutralproduct/pr
AbbVie Delivers 400% Returns Beating The S&P 500 by 139%
Yahoo Finance86 · bullishgeneral
MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion
Morningstar67 · bullishproduct/pr
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic
Yahoo Finance58 · neutralproduct/pr
Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data
Yahoo Top34 · bearishearnings
AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®
Yahoo Top67 · bullishproduct/pr
Abivax stock plunges on cancer signal in ulcerative colitis trial
Yahoo Top22 · bearishanalyst
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?
Yahoo Top67 · bullishproduct/pr
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
PR Newswire50 · neutralgeneral
AbbVie gains EU approval of atogepant for acute migraine
Seeking Alpha77 · bullishproduct/pr
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Top50 · neutralgeneral
AbbVie Inc. (ABBV) Presents at EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities Transcript
Seeking Alpha58 · neutralproduct/pr
AbbVie Advances New Autoimmune Drug ABBV-519 Into First-in-Human Trial, Signaling Next Wave in Immunology
TipRanks67 · bullishproduct/pr
AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
Barchart58 · neutralgeneral
AbbVie gains approval of Decnupaz for rare hematologic malignancy
Seeking Alpha77 · bullishproduct/pr
Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
Seeking Alpha67 · bullishproduct/pr
Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight
PR Newswire67 · bullishproduct/pr
Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress
Yahoo Top61 · neutralanalyst
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
Yahoo Top33 · bearishpotus